Review article · 2024 · Open access
Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes
Pharmacology & Therapeutics, 263, 108725 · Published 23 September 2024 · DOI 10.1016/j.pharmthera.2024.108725
In brief
“Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes” is a 2024 review article by Janarthanan Venkatesan and 8 co-authors, published in Pharmacology & Therapeutics. OpenAlex counts 50 citations as of 21 November 2026. It is open access: the full text is free to read at SSRN Electronic Journal.
- Citations
- 50
- Most cited in
- 2026 (34)
- Field-weighted impact
- 1.63
- References
- 136
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Venkatesan, J., Murugan, D., Lakshminarayanan, K., Smith, A. R., Thirumalaiswamy, H. V., Kandhasamy, H., Zender, B., Zheng, G., & Rangasamy, L. (2024). Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes. Pharmacology & Therapeutics, 263, 108725. https://doi.org/10.1016/j.pharmthera.2024.108725
MLA 9
Venkatesan, Janarthanan, et al. “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes.” Pharmacology & Therapeutics, vol. 263, 2024, p. 108725. https://doi.org/10.1016/j.pharmthera.2024.108725.
Chicago
Venkatesan, Janarthanan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender, Guangrong Zheng, and Loganathan Rangasamy. 2024. “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes.” Pharmacology & Therapeutics 263: 108725. https://doi.org/10.1016/j.pharmthera.2024.108725.
Harvard
Venkatesan, J. et al. (2024) ‘Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes’, Pharmacology & Therapeutics, 263, p. 108725. doi:10.1016/j.pharmthera.2024.108725.
IEEE
J. Venkatesan et al., “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes,” Pharmacology & Therapeutics, vol. 263, p. 108725, 2024, doi: 10.1016/j.pharmthera.2024.108725.
BibTeX
@article{venkatesan2024powering,
title = {{Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes}},
author = {Venkatesan, Janarthanan and Murugan, Dhanashree and Lakshminarayanan, Kalaiarasu and Smith, Alexis R. and Thirumalaiswamy, Harashkumar Vasanthakumari and Kandhasamy, Hariprasath and Zender, Boutheina and Zheng, Guangrong and Rangasamy, Loganathan},
journal = {Pharmacology \& Therapeutics},
year = {2024},
volume = {263},
pages = {108725},
doi = {10.1016/j.pharmthera.2024.108725},
url = {https://doi.org/10.1016/j.pharmthera.2024.108725}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 1 | |
| 2025 | 15 | |
| 2026 | 34 |
Its field-weighted citation impact is 1.63: it has been cited 1.63 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- targeted protein degradation
- PROTACs
- lysosome-targeting chimeras
- molecular glues
- antibody conjugates
- cancer therapeutics
- drug delivery challenges
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Venkatesan, J., Murugan, D., Lakshminarayanan, K., Smith, A. R., Thirumalaiswamy, H. V., Kandhasamy, H., Zender, B., Zheng, G., & Rangasamy, L. (2024). Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes. Pharmacology & Therapeutics, 263, 108725. https://doi.org/10.1016/j.pharmthera.2024.108725
How many times has this paper been cited?
50 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at SSRN Electronic Journal: sign in and open the full text from this page.
Who wrote this paper?
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender, Guangrong Zheng, Loganathan Rangasamy.
What is the DOI of this paper?
10.1016/j.pharmthera.2024.108725, permanently at https://doi.org/10.1016/j.pharmthera.2024.108725. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.